12:00 AM
 | 
Aug 06, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

MultiHance gadobenate dimeglumine regulatory update

Bracco said FDA approved MultiHance gadobenate dimeglumine injection for use in magnetic resonance angiography ( MRA) imaging to evaluate adults with known...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >